Info

Averion International Corp. (Averion) is a clinical research organization (CRO) focused on providing clinical research services and solutions to the pharmaceutical, biotechnology and medical device industries. The Company has a therapeutic focus in oncology, cardiovascular and medical devices. Averion’s core capability is in consulting, product agency registration support, trial design, site selection, project management, medical and site monitoring, data management, biostatistical analysis and reporting, pharmacovigilance, medical writing, and full clinical trial management and consulting services throughout the clinical trials lifecycle. In addition, it is able to manage the subtleties and special requirements of all phases of clinical research, such as Phase I, Phase II, Phase III and Phase IV clinical trials. On October 31, 2007, Averion acquired Hesperion AG. On October 3, 2007, the Company sold its staffing services operating segment.(Source: 10KSB)